310. Development of Generation X Recombinant AAV Vectors for Human Gene Therapy

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33919-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2019English

309. Optimization of Dual AAV Vectors for Gene Therapy of Inherited Retinal Diseases

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

308. Inclusion of Heterologous ITRs in Dual AAV Vectors for Retinal Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Recombinant AAV-mediated VEGF Gene Therapy Induces Mandibular Condylar Growth

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2007English

Developing Immunologically Inert Adeno-Associated Virus (AAV) Vectors for Gene Therapy: Possibilities and Limitations

Current Pharmaceutical Biotechnology
BiotechnologyPharmaceutical Science
2014English

Development of HIV Vectors for Anti-Hiv Gene Therapy.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Engineered AAV Vectors for Improved Central Nervous System Gene Delivery

Neurogenesis
Developmental NeuroscienceDevelopmental Biology
2015English

Adenovirus Vectors for Gene Therapy

Uirusu. Journal of virology
Medicine
2003English

Baculoviruses as Vectors for Gene Therapy Against Human Prostate Cancer

Journal of Biomedicine and Biotechnology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy